Related Experiment Video
Updated: Jun 20, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Conidiobolomycosis in relapsed acute lymphoblastic leukemia
Nita Radhakrishnan1, Anupam Sachdeva, Jaswinder Oberoi
1Pediatric Hematology Oncology and BMT Unit, Department of Pediatrics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India.
Emerging fungal infections pose a significant threat to immunocompromised children with blood cancers. This case highlights Conidiobolus coronatus, a rare zygomycetes, causing invasive infection in a child with acute lymphoblastic leukemia.
Area of Science:
- Mycology
- Hematology
- Pediatric Oncology
Background:
- Invasive fungal infections (IFIs) are a leading cause of death in children with hematological malignancies.
- Fungal pathogens beyond Candida and Aspergillus are increasingly recognized as significant threats.
- Emerging fungal infections present unique challenges in epidemiology and treatment for immunocompromised hosts.
Observation:
- This report details the isolation of Conidiobolus coronatus, a zygomycetes fungus, from a pediatric patient.
- The patient was diagnosed with acute lymphoblastic leukemia and presented with an invasive fungal infection.
- Conidiobolus typically causes sino-respiratory infections but can be angioinvasive and disseminate.
Findings:
- Conidiobolus coronatus, a rare zygomycetes, was identified as the causative agent of invasive fungal infection.
- The infection occurred in a pediatric patient with acute lymphoblastic leukemia, a high-risk immunocompromised state.
- The angioinvasive potential and dissemination risk of Conidiobolus were observed in this case.
Implications:
- This case underscores the importance of considering rare fungal pathogens in immunocompromised children.
- There is a critical need for further research into the diagnosis and management of Conidiobolus infections.
- Establishing consensus on effective antifungal treatment strategies for Conidiobolus is essential for improving patient outcomes.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Treatment Resistent Cancers
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Leishmaniasis